UBS AM’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $227M | Sell |
1,035,773
-98,933
| -9% | -$21.6M | 0.05% | 368 |
|
2025
Q1 | $254M | Buy |
1,134,706
+343,997
| +44% | +$77M | 0.07% | 310 |
|
2024
Q4 | $259M | Buy |
790,709
+107,359
| +16% | +$35.2M | 0.06% | 301 |
|
2024
Q3 | $205M | Buy |
683,350
+122,361
| +22% | +$36.7M | 0.05% | 344 |
|
2024
Q2 | $185M | Buy |
560,989
+180,662
| +48% | +$59.5M | 0.05% | 321 |
|
2024
Q1 | $150M | Sell |
380,327
-34,397
| -8% | -$13.6M | 0.05% | 338 |
|
2023
Q4 | $146M | Buy |
414,724
+48,167
| +13% | +$17M | 0.06% | 334 |
|
2023
Q3 | $138M | Sell |
366,557
-28,488
| -7% | -$10.7M | 0.06% | 324 |
|
2023
Q2 | $137M | Hold |
395,045
| – | – | 0.07% | 322 |
|
2023
Q1 | $137M | Sell |
395,045
-1,841
| -0.5% | -$638K | 0.07% | 322 |
|
2022
Q4 | $93.4M | Sell |
396,886
-48,844
| -11% | -$11.5M | 0.05% | 401 |
|
2022
Q3 | $110M | Sell |
445,730
-19,784
| -4% | -$4.87M | 0.06% | 343 |
|
2022
Q2 | $141M | Sell |
465,514
-93,560
| -17% | -$28.3M | 0.07% | 289 |
|
2022
Q1 | $230M | Buy |
559,074
+15,502
| +3% | +$6.37M | 0.1% | 226 |
|
2021
Q4 | $255M | Buy |
543,572
+39,497
| +8% | +$18.5M | 0.1% | 222 |
|
2021
Q3 | $214M | Buy |
504,075
+11,672
| +2% | +$4.96M | 0.09% | 237 |
|
2021
Q2 | $177M | Buy |
492,403
+18,822
| +4% | +$6.76M | 0.08% | 283 |
|
2021
Q1 | $133M | Buy |
473,581
+14,319
| +3% | +$4.03M | 0.06% | 344 |
|
2020
Q4 | $130M | Buy |
459,262
+88,019
| +24% | +$24.9M | 0.06% | 331 |
|
2020
Q3 | $102M | Buy |
371,243
+25,746
| +7% | +$7.08M | 0.05% | 339 |
|
2020
Q2 | $78.5M | Buy |
345,497
+126,820
| +58% | +$28.8M | 0.05% | 369 |
|
2020
Q1 | $33.3M | Buy |
218,677
+33,867
| +18% | +$5.16M | 0.02% | 566 |
|
2019
Q4 | $27.8M | Buy |
184,810
+76,766
| +71% | +$11.5M | 0.02% | 688 |
|
2019
Q3 | $15.3M | Buy |
108,044
+4,248
| +4% | +$602K | 0.01% | 828 |
|
2019
Q2 | $13M | Sell |
103,796
-10,995
| -10% | -$1.38M | 0.01% | 874 |
|
2019
Q1 | $12.6M | Buy |
114,791
+10,351
| +10% | +$1.14M | 0.01% | 869 |
|
2018
Q4 | $10.2M | Buy |
104,440
+11,687
| +13% | +$1.15M | 0.01% | 868 |
|
2018
Q3 | $11.5M | Buy |
92,753
+1,218
| +1% | +$150K | 0.01% | 905 |
|
2018
Q2 | $9.09M | Buy |
91,535
+1,251
| +1% | +$124K | 0.01% | 971 |
|
2018
Q1 | $7.97M | Buy |
90,284
+6,861
| +8% | +$606K | 0.01% | 993 |
|
2017
Q4 | $8.23M | Buy |
83,423
+200
| +0.2% | +$19.7K | 0.01% | 965 |
|
2017
Q3 | $8.01M | Buy |
83,223
+13,464
| +19% | +$1.3M | 0.01% | 950 |
|
2017
Q2 | $6.59M | Sell |
69,759
-42,900
| -38% | -$4.05M | 0.01% | 978 |
|
2017
Q1 | $9.19M | Buy |
112,659
+14,651
| +15% | +$1.2M | 0.01% | 899 |
|
2016
Q4 | $8.31M | Sell |
98,008
-5,043
| -5% | -$428K | 0.01% | 904 |
|
2016
Q3 | $7.68M | Buy |
103,051
+1,016
| +1% | +$75.7K | 0.01% | 935 |
|
2016
Q2 | $7.74M | Buy |
102,035
+57,056
| +127% | +$4.33M | 0.01% | 926 |
|
2016
Q1 | $3.12M | Sell |
44,979
-2,503
| -5% | -$174K | ﹤0.01% | 1185 |
|
2015
Q4 | $2.86M | Sell |
47,482
-3,112
| -6% | -$187K | ﹤0.01% | 1271 |
|
2015
Q3 | $2.74M | Buy |
50,594
+17,511
| +53% | +$947K | ﹤0.01% | 1278 |
|
2015
Q2 | $1.92M | Buy |
33,083
+2,485
| +8% | +$144K | ﹤0.01% | 1416 |
|
2015
Q1 | $1.84M | Buy |
30,598
+4,900
| +19% | +$295K | ﹤0.01% | 1396 |
|
2014
Q4 | $1.37M | Buy |
25,698
+1,200
| +5% | +$63.9K | ﹤0.01% | 1486 |
|
2014
Q3 | $1.1M | Hold |
24,498
| – | – | ﹤0.01% | 1540 |
|
2014
Q2 | $1.03M | Buy |
24,498
+800
| +3% | +$33.7K | ﹤0.01% | 1570 |
|
2014
Q1 | $1.04M | Buy |
23,698
+600
| +3% | +$26.4K | ﹤0.01% | 1547 |
|
2013
Q4 | $1.13M | Sell |
23,098
-300
| -1% | -$14.7K | ﹤0.01% | 1469 |
|
2013
Q3 | $963K | Hold |
23,398
| – | – | ﹤0.01% | 1528 |
|
2013
Q2 | $822K | Buy |
+23,398
| New | +$822K | ﹤0.01% | 1525 |
|